{{Rsnum
|rsid=17429138
|Chromosome=3
|position=189527804
|Orientation=plus
|GMAF=0.2006
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 46.0 | 40.7 | 13.3
| HCB | 78.8 | 19.0 | 2.2
| JPT | 74.3 | 23.9 | 1.8
| YRI | 100.0 | 0.0 | 0.0
| ASW | 89.5 | 10.5 | 0.0
| CHB | 78.8 | 19.0 | 2.2
| CHD | 86.2 | 11.9 | 1.8
| GIH | 44.6 | 45.5 | 9.9
| LWK | 98.2 | 1.8 | 0.0
| MEX | 65.5 | 27.6 | 6.9
| MKK | 84.0 | 15.4 | 0.6
| TSI | 40.2 | 47.1 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21610222
|Title=Variation in TP63 is associated with lung adenocarcinoma in the UK population
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}